2Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol, 2000,62 ( 3 ) : 299- 307.
3Firpi R J, Nelson DR. Viral Hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program, 2006:375-380.
4Cheng AL. Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non- Hodgkin's lymphoma. Blood, 1996,87 ( 3 ) : 1202.
5Vassiliadis T, Garipidou V, Tziomalos K, et al. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy-a prospective case series. Am J Hematol, 2005, 80(3) :197-203.
2Kuniyoshi M,Nakamuta M,Sakai H.Prevalence of hepatitis B or C virus infectitons m patients with non-Hodgkin's lymphoma[J].J Gastroenterol Hepatol,2001,16(2):215-219
3Marcucci F,Mele A,Spada E,et al.High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma[J].Haematologica,2006,91 (4):554-557.
2CHENG A L, HSIUNG C A, SU I J, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma [ J ] . Hepatology, 2003, 37(6): 1320-1328.
3YEO W, CHAN T C, LEUNG N W, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab [ J ] . J Clin Oncol, 2009, 27(4): 605-611.
4KOO Y X, TAN D S, TAO M, et al. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy [ J ] . Cancer, 2010, 116(1): 115-121.
5FUKUSHIMA N, MIZUTA T, TANAKA M, et al. Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier [ J ] . Ann Oncol, 2009, 20(12): 2013-2017.
6YUKI N, NAGAOKA T, YAMASHIRO M, et al. Longterm histologic and virologic outcomes of acute self-limited hepatitis B [ J ]. Hepatology, 2003, 37(5): 1172-1179.
7PEI S N, CHEN C H, LEE C M, et al. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients [ J ] . Ann Hematol, 2010, 89(3): 255-262.
